Prescribing information

 

    

About Interstellar

The Interstellar: Developing Future Leaders programme has been co-created by Novartis and a steering committee of medical experts, to provide education in rheumatology, support innovative service delivery and facilitate the sharing of clinical excellence to improve patient outcomes in patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).

 

Introducing the Interstellar: Developing Future Leaders programme

The Interstellar: Developing Future Leaders programme consists of three workshop-led meetings that provide an enhanced learning opportunity for experienced and future leaders in the field of PsA and axSpA (AS and nr-axSpA), who will help pave the way to advance research and improve patient care in rheumatology.

Members of the Interstellar: Developing Future Leaders programme have the opportunity to meet with rheumatology experts to share knowledge and practical information on best practice approaches to disease management and service delivery. 

Interstellar 2020 meetings timeline

Setting the foundations for a strong future in PsA and AS


Nurturing knowledge and communicating with conviction as a leading healthcare professional

Advancing research in PsA and axSpA (AS and nr-axSpA)


Enabling evidence generation and addressing unmet research needs

Leading improvement and innovation in PsA and axSpA (AS and nr-axSpA) clinical practice


Driving change and service optimisation as a team leader

 

COS20-R121ag October 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]